hematopoietic system
| N |
• pIpC-treated mice exhibit normal numbers of megakaryocytes in the bone marrow
|
|
• pIpC-treated mice exhibit abnormal morphology of terminally differentiated megakaryocytes
|
|
• giant platelets with increased number of microtubule coils in pIpC-treated mice
|
|
• severe in pIpC-treated mice whether or not mice are splenectomized
|
|
• in pIpC-treated mice
|
homeostasis/metabolism
|
• in pIpC-treated mice whether or not mice are splenectomized
|
cellular
|
• pIpC-treated mice exhibit abnormal morphology of terminally differentiated megakaryocytes
|


Analysis Tools